Goldman Sachs Group Inc Aurinia Pharmaceuticals Inc. Put Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AUPH
# of Institutions
207Shares Held
58.3MCall Options Held
914KPut Options Held
1.35M-
Black Rock Inc. New York, NY9.27MShares$76.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$67.9 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$59.9 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.9 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$24.4 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.17B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...